HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Favorable response to aggressive chemotherapy in a patient with primary plasma cell leukemia.

Abstract
Primary plasma cell leukemia was diagnosed in a previously healthy 58-year-old man. The unusual presentation with concomitant multiple osteolytic lesions and hepatosplenomegaly, the favorable response to aggressive chemotherapy with COAP, and the relatively long survival of 22 months prompted this report. This and several other cases recently reported should encourage an aggressive therapeutic approach to this disease.
AuthorsM Lishner, R Lang, I Jutrin, M Ravid
JournalActa haematologica (Acta Haematol) Vol. 74 Issue 1 Pg. 49-51 ( 1985) ISSN: 0001-5792 [Print] Switzerland
PMID3934909 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Humans
  • Leukemia, Plasma Cell (drug therapy, mortality)
  • Male
  • Middle Aged
  • Prednisone (administration & dosage)
  • Time Factors
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: